Jade Biosciences, Inc. (JBIO) Misses Q2 EPS by 55c

Jade Biosciences, Inc. (NASDAQ: JBIO) reported Q2 EPS of ($0.86), $0.55 worse than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Jade Biosciences, Inc. (JBIO) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• CrowdStrike Holdings Inc. (CRWD) Tops Q1 EPS by 3c, Offers Guidance
• Jade Biosciences (JBIO) PT Raised to $55 at H.C. Wainwright